Professor Hardev Pandha
Founder

Professor Pandha qualified as a doctor at the University of Birmingham and has trained in internal medicine and subsequently in medical oncology at the Royal Postgraduate Medical School, Hammersmith Hospital. He spent four years in research at the CRUK labs at the Hammersmith to gain his PhD in gene therapy, for which he was awarded the McElwain prize. He completed his training at Stanford University in the USA and the Royal Marsden Hospital in London. He was a consultant medical oncologist at St George’s University of London in 2000 before his appointment as Professor of Medical Oncology at Surrey University in 2006. He has been director of the Surrey Cancer Research Institute (SCRI) since 2014.

Professor Pandha specialises in the treatment of prostate, kidney and bladder cancer, and advises a number of companies in early-phase clinical trials of experimental cancer treatments in these fields. Prof Pandha has published over 200 scientific papers and contributed to 14 medical textbooks. He has been a member of advisory boards in the management of urological cancers and editorial board of several medical journals.